Live from the NIH registry
Studies recruiting near Madison right now
Top 25 of 526 recruiting studies, sorted by proximity — each links to its official registry page
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
Stroke
N/A
Interventional 288 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Wisconsin, Madison
Lopinavir/Ritonavir in PLWH With High-Grade AIN
High-Grade Anal Intraepithelial Neoplasia
Phase 1
Interventional 21 participants sought
UW Digestive Health Center Anoscopy Clinic — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Wisconsin, Madison
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
UW Health Comprehensive Program for Bleeding Disorders — Madison, Wisconsin (0.8 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
Delirium, Neurocognitive Disorders
N/A
Interventional 1,900 participants sought
Meriter Hospital — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Michigan
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Narcolepsy Type 1, Narcolepsy Type 2
Phase 2, Phase 3
Interventional 786 participants sought
Alkermes Investigational Site — Madison, Wisconsin (0.8 mi)
· Sponsor: Alkermes, Inc.
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Phase 2
Interventional 113 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi)
· Sponsor: Anagram Therapeutics, Inc.
Clinical Decision Support Tool in PARDS Pilot Study
Ventilation Therapy; Complications, Ventilator-Induced Lung Injury
N/A
Interventional 180 participants sought
University of Wisconsin-Madison — Madison, Wisconsin (0.8 mi)
· Sponsor: Children's Hospital Los Angeles
In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)
Chronic Lymphocytic Leukemia
N/A
Observational 16 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Wisconsin, Madison
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation
Phase 1
Interventional 420 participants sought
University of Wisconsin Hospital and Clinics — Madison, Wisconsin (0.8 mi)
· Sponsor: Kura Oncology, Inc.
An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
Stargardt, Stargardt's Disease
N/A
Observational 75 participants sought
University of Wisconsin, Madison — Madison, Wisconsin (0.8 mi)
· Sponsor: Splice Bio
The Advancing Dynamic And Personalized Training Study
Well-Being, Psychological
N/A
Interventional 1,553 participants sought
Center for Healthy Minds — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Wisconsin, Madison
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
Failed or Difficult Intubation, Sequela, Intubation; Difficult
N/A
Observational 150,000 participants sought
University of Wisconsin - UnityPoint Meriter — Madison, Wisconsin (0.8 mi)
· Sponsor: Children's Hospital of Philadelphia
OAR-Based, Dose Escalated SBRT With Real Time Adaptive MRI Guidance for Liver Metastases
Liver Metastases, Stereotactic Body Radiation Therapy
N/A
Interventional 32 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Wisconsin, Madison
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma
Phase 2
Interventional 90 participants sought
University of Wisconsin-American Family Children's Hospital — Madison, Wisconsin (0.8 mi)
· Sponsor: Carl Allen
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
N/A
Observational 700 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi)
· Sponsor: Novartis Pharmaceuticals
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia (CLL)
Phase 2
Interventional 75 participants sought
University of Wisconsin-Madiso /ID# 232612 — Madison, Wisconsin (0.8 mi)
· Sponsor: AbbVie
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Recurrent Glioblastoma, IDH-Wildtype, Recurrent MGMT-Methylated Glioblastoma
Phase 1, Phase 2
Interventional 97 participants sought
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center — Madison, Wisconsin (0.8 mi)
· Sponsor: National Cancer Institute (NCI)
Resistant Potato Starch to Alleviate GWI
Gulf War Illness
Phase 2
Interventional 52 participants sought
William S. Middleton Memorial Veterans Hospital, Madison, WI — Madison, Wisconsin (0.8 mi)
· Sponsor: VA Office of Research and Development
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University Telemedicine — Madison, Wisconsin (0.8 mi)
· Sponsor: Sameek Roychowdhury
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
University of Wisconsin-Madison ( Site 0024) — Madison, Wisconsin (0.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
Well-being Skills for Reentry
Formerly Incarcerated Adults
N/A
Interventional 60 participants sought
University of Wisconsin — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Wisconsin, Madison
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center — Madison, Wisconsin (0.8 mi)
· Sponsor: Pfizer
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Madison, Wisconsin (0.8 mi)
· Sponsor: Daiichi Sankyo
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
University of Wisconsin - Carbone Cancer Center — Madison, Wisconsin (0.8 mi)
· Sponsor: C4 Therapeutics, Inc.
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
Phase 1
Interventional 22 participants sought
University of Wisconsin Carbone Cancer Center — Madison, Wisconsin (0.8 mi)
· Sponsor: University of Wisconsin, Madison